lonafarnib has been researched along with Microbial Superinvasion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilman, C; Heller, T; Koh, C | 1 |
| Caviglia, GP; Ibadullaeva, N; Ismoilov, U; Joldasova, E; Khikmatullaeva, A; Khodjaeva, M; Musabaev, E; Rizzetto, M; Said, S; Shahnoza, A | 1 |
1 review(s) available for lonafarnib and Microbial Superinvasion
| Article | Year |
|---|---|
Chronic hepatitis delta: A state-of-the-art review and new therapies.
Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Global Burden of Disease; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon-alpha; Lipopeptides; Organic Anion Transporters, Sodium-Dependent; Piperidines; Pyridines; Randomized Controlled Trials as Topic; Review Literature as Topic; Superinfection; Symporters; Therapies, Investigational; Treatment Outcome; Virus Assembly; Virus Internalization | 2019 |
1 other study(ies) available for lonafarnib and Microbial Superinvasion
| Article | Year |
|---|---|
Hepatitis D virus in Uzbekistan.
Topics: Adult; Chronic Disease; Female; Fibrosis; Global Burden of Disease; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Incidence; Interferon-alpha; Lipopeptides; Liver Diseases; Male; Middle Aged; Piperidines; Prevalence; Pyridines; Risk Factors; Superinfection; Uzbekistan | 2020 |